The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Hepatic Encephalopathy

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Hepatic Encephalopathy

 

Psychiatry related information on Hepatic Encephalopathy

 

High impact information on Hepatic Encephalopathy

 

Chemical compound and disease context of Hepatic Encephalopathy

 

Biological context of Hepatic Encephalopathy

 

Anatomical context of Hepatic Encephalopathy

 

Gene context of Hepatic Encephalopathy

 

Analytical, diagnostic and therapeutic context of Hepatic Encephalopathy

References

  1. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. Basile, A.S., Hughes, R.D., Harrison, P.M., Murata, Y., Pannell, L., Jones, E.A., Williams, R., Skolnick, P. N. Engl. J. Med. (1991) [Pubmed]
  2. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. Ramond, M.J., Poynard, T., Rueff, B., Mathurin, P., Théodore, C., Chaput, J.C., Benhamou, J.P. N. Engl. J. Med. (1992) [Pubmed]
  3. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky, G., Meier, P.J., Riederer, E., Walser, H., Ziegler, W.H., Schmid, M. Gastroenterology (1989) [Pubmed]
  4. Hepatic encephalopathy in rats with thioacetamide-induced acute liver failure is not mediated by endogenous benzodiazepines. Püspök, A., Herneth, A., Steindl, P., Ferenci, P. Gastroenterology (1993) [Pubmed]
  5. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Bosman, D.K., van den Buijs, C.A., de Haan, J.G., Maas, M.A., Chamuleau, R.A. Gastroenterology (1991) [Pubmed]
  6. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Taylor-Robinson, S.D., Sargentoni, J., Mallalieu, R.J., Bell, J.D., Bryant, D.J., Coutts, G.A., Morgan, M.Y. Hepatology (1994) [Pubmed]
  7. Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide, and octanoic acid. Zeneroli, M.L., Ventura, E., Baraldi, M., Penne, A., Messori, E., Zieve, L. Hepatology (1982) [Pubmed]
  8. Effects of the histamine H(1) receptor blocker, pyrilamine, on spontaneous locomotor activity of rats with long-term portacaval anastomosis. Lozeva, V., Valjakka, A., Lecklin, A., Olkkonen, H., Hippeläinen, M., Itkonen, M., Plumed, C., Tuomisto, L. Hepatology (2000) [Pubmed]
  9. Decrease in cerebral inositols in rats and humans. Moats, R.A., Lien, Y.H., Filippi, D., Ross, B.D. Biochem. J. (1993) [Pubmed]
  10. Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy. Gooday, R., Hayes, P.C., Bzeizi, K., O'Carroll, R.E. Psychopharmacology (Berl.) (1995) [Pubmed]
  11. Benzodiazepine compounds and hepatic encephalopathy. Mullen, K.D. N. Engl. J. Med. (1991) [Pubmed]
  12. Hypernatremia and lactulose therapy. Nelson, D.C., McGrew, W.R., Hoyumpa, A.M. JAMA (1983) [Pubmed]
  13. Lactulose (cephulac) in portosystemic encephalopathy. Kosman, M.E. JAMA (1976) [Pubmed]
  14. Cerebral glucose metabolism after portacaval shunting in the rat. Patterns of metabolism and implications for the pathogenesis of hepatic encephalopathy. Lockwood, A.H., Ginsberg, M.D., Rhoades, H.M., Gutierrez, M.T. J. Clin. Invest. (1986) [Pubmed]
  15. Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity. Maddison, J.E., Dodd, P.R., Johnston, G.A., Farrell, G.C. Gastroenterology (1987) [Pubmed]
  16. Tryptophan and hepatic encephalopathy. Cangiano, C., Rossi Fanelli, F., Cascino, A., Capocaccia, L. Gastroenterology (1979) [Pubmed]
  17. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Häussinger, D., Laubenberger, J., vom Dahl, S., Ernst, T., Bayer, S., Langer, M., Gerok, W., Hennig, J. Gastroenterology (1994) [Pubmed]
  18. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Conn, H.O., Leevy, C.M., Vlahcevic, Z.R., Rodgers, J.B., Maddrey, W.C., Seeff, L., Levy, L.L. Gastroenterology (1977) [Pubmed]
  19. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Pappas, S.C., Ferenci, P., Schafer, D.F., Jones, E.A. Gastroenterology (1984) [Pubmed]
  20. Decarboxylation to tyramine: an important route of tyrosine metabolism in dogs with experimental hepatic encephalopathy. Faraj, B.A., Ali, F.M., Ansley, J.D., Malveaux, E.J. Gastroenterology (1978) [Pubmed]
  21. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Lesesne, H.R., Bozymski, E.M., Fallon, H.J. Gastroenterology (1978) [Pubmed]
  22. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Cai, J., Ito, M., Nagata, H., Westerman, K.A., Lafleur, D., Chowdhury, J.R., Leboulch, P., Fox, I.J. Hepatology (2002) [Pubmed]
  23. Function of the autonomic nervous system in patients with hepatic encephalopathy. Lenz, K., Hörtnagl, H., Magometschnigg, D., Kleinberger, G., Druml, W., Laggner, A. Hepatology (1985) [Pubmed]
  24. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Mullen, K.D., Szauter, K.M., Kaminsky-Russ, K. Lancet (1990) [Pubmed]
  25. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy. Knudsen, G.M., Schmidt, J., Almdal, T., Paulson, O.B., Vilstrup, H. Hepatology (1993) [Pubmed]
  26. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Zimmermann, C., Ferenci, P., Pifl, C., Yurdaydin, C., Ebner, J., Lassmann, H., Roth, E., Hörtnagl, H. Hepatology (1989) [Pubmed]
  27. Plasma GABA-like activity in rats with hepatic encephalopathy is due to GABA and taurine. Maddison, J.E., Leong, D.K., Dodd, P.R., Johnston, G.A. Hepatology (1990) [Pubmed]
  28. Alterations of [3H]8-OH-DPAT and [3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Rao, V.L., Butterworth, R.F. Neurosci. Lett. (1994) [Pubmed]
  29. Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Kimura, T., Budka, H. Acta Neuropathol. (1986) [Pubmed]
  30. Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Rao, V.L., Giguère, J.F., Layrargues, G.P., Butterworth, R.F. Brain Res. (1993) [Pubmed]
  31. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. Romero-Gómez, M., Ramos-Guerrero, R., Grande, L., de Terán, L.C., Corpas, R., Camacho, I., Bautista, J.D. J. Hepatol. (2004) [Pubmed]
  32. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids. Bauer, A.G., Wilson, J.H., Lamberts, S.W., Blom, W. Hepatogastroenterology (1983) [Pubmed]
  33. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Ferenci, P., Grimm, G., Meryn, S., Gangl, A. Gastroenterology (1989) [Pubmed]
  34. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Navasa, M., Follo, A., Llovet, J.M., Clemente, G., Vargas, V., Rimola, A., Marco, F., Guarner, C., Forné, M., Planas, R., Bañares, R., Castells, L., Jimenez De Anta, M.T., Arroyo, V., Rodés, J. Gastroenterology (1996) [Pubmed]
  35. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances. Jones, E.A., Skolnick, P., Gammal, S.H., Basile, A.S., Mullen, K.D. Ann. Intern. Med. (1989) [Pubmed]
  36. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Horst, D., Grace, N.D., Conn, H.O., Schiff, E., Schenker, S., Viteri, A., Law, D., Atterbury, C.E. Hepatology (1984) [Pubmed]
 
WikiGenes - Universities